Portal de Periódicos da CAPES

ANGIOGENESIS AND ANGIOGENIC GROWTH FACTORS IN WILMS TUMOR

2001; Lippincott Williams & Wilkins; Volume: 165; Issue: 6 Part 2 Linguagem: Inglês

10.1016/s0022-5347(05)66183-6

1527-3792

Erik Sköldenberg, Johan Christiansson, Bengt Sandstedt, Anders Larsson, Göran Läckgren, Rolf Christofferson,

Renal cell carcinoma treatment

No AccessJournal of UrologyOncology1 Jun 2001ANGIOGENESIS AND ANGIOGENIC GROWTH FACTORS IN WILMS TUMOR ERIK G. SKÖLDENBERG, JOHAN CHRISTIANSSON, BENGT SANDSTEDT, ANDERS LARSSON, GÖRAN LÄCKGREN, and ROLF CHRISTOFFERSON ERIK G. SKÖLDENBERGERIK G. SKÖLDENBERG , JOHAN CHRISTIANSSONJOHAN CHRISTIANSSON , BENGT SANDSTEDTBENGT SANDSTEDT , ANDERS LARSSONANDERS LARSSON , GÖRAN LÄCKGRENGÖRAN LÄCKGREN , and ROLF CHRISTOFFERSONROLF CHRISTOFFERSON View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)66183-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Angiogenesis, that is new blood vessel formation, is a prerequisite for growth and metastasis of solid tumors. This study was undertaken to quantify tumor capillaries, investigate immunohistochemical expression and measure serum concentrations of angiogenic growth factors in patients with Wilms tumor. Materials and Methods: The hospital records of 33 patients were reviewed and new slides were stained for the endothelial cell marker CD31. Capillaries were quantified in the most vascularized part of the tumor (hot spot) and in the whole slide. New slides were stained immunohistochemically for the angiogenic growth factors angiogenin, basic fibroblast growth factor (bFGF), transforming growth factor α, transforming growth factor β1–3, tumor necrosis factor α and vascular endothelial growth factor (VEGF), and their immunoreactivity was quantified. Pretreatment serum samples from 14 patients and 56 healthy control children were analyzed using enzyme-linked immunosorbent assay kits for angiogenin, basic fibroblast growth factor, epidermal growth factor, hepatocyte growth factor, tumor necrosis factor α and VEGF. Results: Logistic regression analysis and Kaplan-Meier estimates showed that quantifications based on the tumor hot spot had a significant impact on survival probability (p <0.05). The tumor hot spot counts were highest in the blastemal compartment. Levels of hepatocyte growth factor and VEGF in serum were 3 times higher than those in controls (p <0.01). Conclusions: Although the sample size is small in this study, the results imply that angiogenesis in Wilms tumor is driven by angiogenic growth factors, and that intratumoral capillary quantification and determinations of serum levels of angiogenic growth factors may be of clinical value. References 1 : Clinical applications of research on angiogenesis. N Engl J Med1995; 333: 1757. Crossref, Medline, Google Scholar 2 : Antiangiogenic therapy. In: Cancer: Principles and Practice of Oncology. Edited by . Philadelphia: Lippincott-Raven Publishers1997: 3075. Google Scholar 3 : Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res1999; 59: 856. Medline, Google Scholar 4 : Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology1999; 55: 575. Crossref, Google Scholar 5 : Results of the United Kingdom Children's Cancer Study Group first Wilms' tumor study. J Clin Oncol1995; 13: 124. Crossref, Medline, Google Scholar 6 : Results of the 6th International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol1993; 11: 1014. Crossref, Medline, Google Scholar 7 : Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med1991; 324: 1. Crossref, Medline, Google Scholar 8 : Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat1995; 36: 181. Crossref, Medline, Google Scholar 9 : Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest1998; 78: 1563. Medline, Google Scholar 10 : Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J Pediatr Surg1999; 34: 743. Crossref, Medline, Google Scholar 11 : Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin Cancer Res1995; 1: 327. Medline, Google Scholar 12 : Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer1996; 32: 2474. Crossref, Google Scholar 13 : Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J1986; 18: 271. Crossref, Medline, Google Scholar 14 : Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS1988; 96: 379. Crossref, Medline, Google Scholar 15 : Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol1996; 14: 405. Crossref, Medline, Google Scholar 16 : Histological analysis of aggressiveness and responsiveness in Wilms' tumor. Med Pediatr Oncol1996; 27: 422. Crossref, Medline, Google Scholar 17 : New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol1999; 32: 317. Crossref, Medline, Google Scholar 18 : Distribution of subtypes in standard Wilms' tumor after pre-operative chemotherapy and its possible influence on the patients' cure rate. Med Pediatr Oncol1994; 23: 217. Google Scholar 19 : Pretreatment, ultrasound-guided cutting needle biopsies in childhood renal tumors. Med Pediatr Oncol1999; 32: 283. Crossref, Medline, Google Scholar 20 : The physiology of transforming growth factor-alpha. Adv Cancer Res1992; 58: 27. Crossref, Medline, Google Scholar 21 : Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma: the Nordic Myeloma Study Group. Blood1998; 91: 806. Crossref, Medline, Google Scholar 22 : Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients. Lung Cancer1997; 17: 211. Crossref, Medline, Google Scholar 23 : Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer1997; 76: 238. Crossref, Medline, Google Scholar 24 : Tumour angiogenesis factor (TAF) in human and animal tumours. Int J Cancer1976; 17: 549. Crossref, Medline, Google Scholar 25 : Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst1994; 86: 356. Crossref, Medline, Google Scholar 26 : Tumor angiogenesis: therapeutic implications. N Engl J Med1971; 285: 1182. Crossref, Medline, Google Scholar 27 : Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell1997; 88: 277. Crossref, Medline, Google Scholar 28 : Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science1999; 285: 1926. Crossref, Medline, Google Scholar 29 : Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor. J Pediatr Surg2000; 35: 30. Crossref, Medline, Google Scholar 30 : The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology. Med Pediatr Oncol1996; 26: 145. Crossref, Medline, Google Scholar From the Department of Surgery, Section of Pediatric Surgery, University Children's Hospital, Department of Medical Cell Biology, Uppsala University and Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, and Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Hospital, Stockholm, Sweden© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Abdel-Monem M, El-Khawaga O, Awadalla A, Hafez A, Ahmed A, Abdelhameed M and Abdelhalim A (2022) Gene expression analysis and the risk of relapse in favorable histology Wilms' tumorArab Journal of Urology, 10.1080/2090598X.2022.2127202, VOL. 21, NO. 1, (45-51), Online publication date: 2-Jan-2023. Wang J, Fan S, Feng Y, Zhang H, Zou W and Hu C (2019) Antiangiogenic therapy for Wilms tumor in an adult and literature reviewAnti-Cancer Drugs, 10.1097/CAD.0000000000000792, VOL. 30, NO. 6, (640-645), Online publication date: 1-Jul-2019. Mami I and Pallet N (2018) tRNA fragmentation and protein translation dynamics in the course of kidney injuryRNA Biology, 10.1080/15476286.2015.1107704, VOL. 15, NO. 9, (1147-1156), Online publication date: 2-Sep-2018. Schiavetti A, Varrasso G, Collini P and Clerico A (2018) Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse AnaplasiaJournal of Pediatric Hematology/Oncology, 10.1097/MPH.0000000000000934, VOL. 40, NO. 4, (331-333), Online publication date: 1-May-2018. Geller J, Perentesis J, Liu X, Minard C, Kudgus R, Reid J, Fox E, Blaney S and Weigel B (2017) A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)Pediatric Blood & Cancer, 10.1002/pbc.26565, VOL. 64, NO. 11, (e26565), Online publication date: 1-Nov-2017. Mami I, Tavernier Q, Bouvier N, Aboukamis R, Desbuissons G, Rabant M, Poindessous V, Laurent-Puig P, Beaune P, Tharaux P, Thervet E, Chevet E, Anglicheau D and Pallet N (2016) A Novel Extrinsic Pathway for the Unfolded Protein Response in the KidneyJournal of the American Society of Nephrology, 10.1681/ASN.2015060703, VOL. 27, NO. 9, (2670-2683), Online publication date: 1-Sep-2016. Mullen E and Graf N (2014) Clinical Presentation Renal Tumors of Childhood, 10.1007/978-3-662-44003-2_3, (39-52), . Geller J and Hohenstein P (2014) Molecular-Targeted Therapy for Pediatric Renal Tumors Renal Tumors of Childhood, 10.1007/978-3-662-44003-2_10, (167-186), . Ramani P, Headford A, Sowa-Avugrah E and Hunt L (2013) Angiogenin expression in human kidneys and Wilms' tumours: relationship with hypoxia and angiogenic factorsInternational Journal of Experimental Pathology, 10.1111/iep.12012, VOL. 94, NO. 2, (115-125), Online publication date: 1-Apr-2013. Schiavetti A, McDowell H, Conti L, Altavista P, Antenucci A, Pizer B and Dominici C (2012) Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcomaPediatric Blood & Cancer, 10.1002/pbc.24072, VOL. 59, NO. 4, (627-630), Online publication date: 1-Oct-2012. Sandoval J, Malkas L and Hickey R (2012) Clinical Significance of Serum Biomarkers in Pediatric Solid Mediastinal and Abdominal TumorsInternational Journal of Molecular Sciences, 10.3390/ijms13011126, VOL. 13, NO. 1, (1126-1153) Yang X, Huang J, Wang K, Li W, Cui L and Li X (2011) Angiogenin-Mediated Photosensitizer-Aptamer Conjugate for Photodynamic TherapyChemMedChem, 10.1002/cmdc.201100226, VOL. 6, NO. 10, (1778-1780), Online publication date: 4-Oct-2011. Sujka-Kordowska P, Malińska A and Zabel M Selected Aspects of Angiogensis in Haematological MalignanciesAdvances in Cell Biology, 10.2478/v10052-011-0002-5, VOL. 3, NO. 2, (17-39) Chen L and Hu G (2010) Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinomaOral Oncology, 10.1016/j.oraloncology.2010.06.011, VOL. 46, NO. 9, (648-653), Online publication date: 1-Sep-2010. Nasir O, Wang K, Föller M, Bhandaru M, Sandulache D, Artunc F, Ackermann T, Ebrahim A, Palmada M, Klingel K, Saeed A and Lang F (2010) Downregulation of Angiogenin Transcript Levels and Inhibition of Colonic Carcinoma by Gum Arabic ( Acacia senegal ) Nutrition and Cancer, 10.1080/01635581003605920, VOL. 62, NO. 6, (802-810), Online publication date: 23-Jul-2010. Ozluk Y (2010) Wilms Tumor: Prognosis Using Microvessel Density Methods of Cancer Diagnosis, Therapy, and Prognosis, 10.1007/978-90-481-2918-8_13, (147-155), . Geller J and Dome J (2010) Molecular Targeted Therapy for Wilms' Tumor Molecularly Targeted Therapy for Childhood Cancer, 10.1007/978-0-387-69062-9_19, (401-424), . Patel S, Zhou G, Liu S, Li M, Jeong J, DeMayo F, Gingras M, Gibbs R, Fisher W and Brunicardi F (2009) Microarray Analysis of Somatostatin Receptor 5-Regulated Gene Expression Profiles in Murine PancreasWorld Journal of Surgery, 10.1007/s00268-008-9893-1, VOL. 33, NO. 4, (630-637), Online publication date: 1-Apr-2009. Adamski J, Estlin E and Makin G (2008) The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancerCancer Treatment Reviews, 10.1016/j.ctrv.2007.11.005, VOL. 34, NO. 3, (231-246), Online publication date: 1-May-2008. Yasemin O, Isin K, Gulluoglu M, Inci A and Veli U (2006) The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumourPathology, 10.1080/00313020600922926, VOL. 38, NO. 5, (408-414), Online publication date: 1-Oct-2006. Yoshioka N, Wang L, Kishimoto K, Tsuji T and Hu G (2006) A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferationProceedings of the National Academy of Sciences, 10.1073/pnas.0606708103, VOL. 103, NO. 39, (14519-14524), Online publication date: 26-Sep-2006. Abramson L, Browne M, Stellmach V, Doll J, Cornwell M, Reynolds M, Arensman R and Crawford S (2006) Pigment epithelium–derived factor targets endothelial and epithelial cells in Wilms' tumorJournal of Pediatric Surgery, 10.1016/j.jpedsurg.2006.04.038, VOL. 41, NO. 8, (1351-1356), Online publication date: 1-Aug-2006. Desrosiers R, Rivard M, Grundy P and Annabi B (2005) Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumorsPediatric Blood & Cancer, 10.1002/pbc.20566, VOL. 46, NO. 1, (40-49), Online publication date: 1-Jan-2006. Abounader R and Laterra J (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisNeuro-Oncology, 10.1215/S1152851705000050, VOL. 7, NO. 4, (436-451), Online publication date: 1-Oct-2005. Rössler J and Lagodny J (2005) Blood and lymph vessels in embryonic tumorsHematological Oncology, 10.1002/hon.756, VOL. 23, NO. 3-4, (94-101), Online publication date: 1-Sep-2005. Ghanem M, van Steenbrugge G, Nijman R and van der Kwast T (2005) Prognostic markers in nephroblastoma (Wilms' tumor)Urology, 10.1016/j.urology.2004.12.005, VOL. 65, NO. 6, (1047-1054), Online publication date: 1-Jun-2005. Shimoyama S (2005) 15 Angiogenin in Gastric Cancer and Its Roles in Malignancy Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma, 10.1016/S1874-5784(05)80077-7, (195-203), . Goligorsky B (2003) Role of VEGF in Kidney Development, Microvascular Maintenance and Pathophysiology of Renal DiseaseThe Korean Journal of Internal Medicine, 10.3904/kjim.2003.18.2.65, VOL. 18, NO. 2, (65-75) Abramson L, Stellmach V, Doll J, Cornwell M, Arensman R and Crawford S (2003) Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium–derived factor in a xenograft modelJournal of Pediatric Surgery, 10.1053/jpsu.2003.50104, VOL. 38, NO. 3, (336-342), Online publication date: 1-Mar-2003. Abramson L, Grundy P, Rademaker A, Helenowski I, Cornwell M, Katzenstein H, Reynolds M, Arensman R and Crawford S (2003) Increased microvascular density predicts relapse in Wilms' tumorJournal of Pediatric Surgery, 10.1053/jpsu.2003.50102, VOL. 38, NO. 3, (325-330), Online publication date: 1-Mar-2003. Tang J, Li S, Li J, Luo Y, Xu J, Zhang Y, Li X, Shi H and Zhang G (2003) Correlation between prostate cancer grade and vascularity on color doppler imaging: Preliminary findingsJournal of Clinical Ultrasound, 10.1002/jcu.10139, VOL. 31, NO. 2, (61-68), Online publication date: 1-Feb-2003. McLorie G (2001) Wilms' tumor (nephroblastoma)Current Opinion in Urology, 10.1097/00042307-200111000-00002, VOL. 11, NO. 6, (567-570), Online publication date: 1-Nov-2001. Volume 165Issue 6 Part 2June 2001Page: 2274-2279 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordsnephroblastomaprognosiskidney neoplasmsneovascularization, pathologicangiogenesis factorMetricsAuthor Information ERIK G. SKÖLDENBERG More articles by this author JOHAN CHRISTIANSSON More articles by this author BENGT SANDSTEDT More articles by this author ANDERS LARSSON More articles by this author GÖRAN LÄCKGREN More articles by this author ROLF CHRISTOFFERSON More articles by this author Expand All Advertisement PDF downloadLoading ...